RhoA prenylation is a critical step for the translocation of RhoA to the membrane and its activation in response to agonistinduced sustained contraction of the smooth muscle. However, the effect and role of RhoA prenylation in the spontaneously tonic smooth muscle, such as internal anal sphincter (IAS), is not known. Present studies determined RhoA prenylation and its association with the basal tone in the IAS before and after the RhoA prenylation inhibitor, geranylgeranyl transferase in-
between RhoA prenylation and Rho kinase (ROCK) activity. GGTI-297 decreased prenylation of RhoA, decreased ROCK activity, and caused a corresponding fall in the IAS tone. These inhibitory effects following RhoA prenylation blockade were demonstrated to be directly on the spontaneously contracted IAS smooth muscle cells. Western blot analysis revealed high levels of RhoA in the IAS smooth muscle cellular membrane in the basal state, and GGTI-297 shifted the RhoA localization to the cytosol. RhoA prenylation may play an important role in the translocation of RhoA to the smooth muscle cell membrane leading to its activation and for the maintenance of basal tone in the IAS.
Internal anal sphincter (IAS) is a tonic smooth muscle that remains contracted at rest via myogenic properties and plays a pivotal role in rectoanal continence (Culver and Rattan, 1986; Schiller, 2002; Rattan, 2005) . Hypertensive IAS is associated with motility disorders like Hirschsprung's disease (Vanderwinden et al., 1993; Rattan, 2005) , recurrent anal fissures, and hemorrhoids (McCallion and Gardiner, 2002; Madoff and Fleshman, 2004) . A decrease in the IAS tone on the other hand results in rectoanal incontinence (Schiller, 2002) . Information regarding molecular mechanisms in the regulation of IAS tone is not currently available. Such information is vital for the understanding of the pathophysiology of the above abnormalities and their therapeutic managements.
Activation of Ser/Thr kinase Rho kinase (ROCK) by
GTP⅐RhoA is a critical step in RhoA-ROCK-mediated Ca 2ϩ sensitization of MLC 20 in the smooth muscle. RhoA cycles between a biologically inactive GDP-bound state and an active GTP-bound state. Thus, in resting cells, the Rho GDP dissociation inhibitor binds to GDP-RhoA and shifts GDPRhoA from the membrane to the cytosol (Somlyo and Somlyo, 2003) (Fig. 1) . With the agonist stimulation of G proteincoupled receptors, guanine nucleotide exchange factors convert GDP-RhoA to GTP-bound RhoA (active form of RhoA). GTP-bound RhoA associates with the plasma membrane via its prenylated tail and then activates ROCK .
RhoA prenylation is one of the requisite steps for the translocation of RhoA to the cellular membrane. RhoA is posttranslationally modified by the isoprenoid lipid geranylgeranyl (Epstein et al., 1991) . In addition, prenyltransferase geranylgeranyltransferase I (GGTase I) catalyzes the covalent attachment of the geranylgeranyl group from geranylgeranyl pyrophosphate (GGPP) to the carboxyl-terminal cysteine of RhoA (Yokoyama et al., 1991; Yokoyama and Gelb, 1993) .
The purpose of the present study was to determine the role of RhoA prenylation in the activation of RhoA and in the maintenance of IAS tone. We determined changes in the IAS tone in the basal and stimulated (by U-46619) state, before and after prenylation inhibitor GGTI-297 (GGTase I-selective inhibitor). We also determined cellular distribution of RhoA and ROCK activity. For comparison, we used phasic rectal smooth muscle (RSM).
Materials and Methods
Tissue Preparation, Culture, and Drug Treatments. Sprague-Dawley rats (300 -350 g) were killed by decapitation. The anal canal with an adjacent region of the rectum was quickly removed and transferred to oxygenated (95% O 2 /5% CO 2 ) Krebs physiological solution of the following composition: 118.07 mM NaCl, 4.69 mM KCl, 2.52 mM CaCl 2 , 1.16 mM MgSO 4 , 1.01 mM NaH 2 PO 4 , 25 mM NaHCO 3 , and 11.10 mM glucose (37°C). Circular smooth muscle strips (ϳ0.5 ϫ 7 mm) of the IAS and the RSM were prepared as explained previously .
IAS and RSM strips were cultured in Leibovitz medium (L-15) (Bolz et al., 2000) with 5% penicillin-streptomycin, 50 g/ml gentamicin, and 2 g/ml amphotericin B at room temperature (RT) in a sterile environment in tissue culture hood. The strips were incubated with either GGTI-297 (0.01, 0.1, and 1 M) or GGTI-297 plus 10 M GGPP. Control set of strips were similarly incubated for 24 h in L-15 medium with the exception of GGTI-297 treatment. The viability of the tissues following 24-h incubation was evident from the development of tone in the IAS and robust responses to U-46619. U-46619 was used since it produces reproducible contraction both in the IAS and RSM.
Measurement of Isometric Tension. Smooth muscle strips prepared above were transferred to 2-ml muscle baths containing oxygenated Krebs physiological solution at 37°C. Isometric tension was measured via force transducers (model FT03; Grass Instruments, Quincy, MA) using the PowerLab/8SP data-acquisition system (AD Instruments, Colorado Springs, CO) using Chart 5 (AD Instruments) (Rattan et al., 2004 De Godoy and Rattan, 2005) . Following 24-h culture, the IAS was characterized by the development of spontaneous tone and relaxation responses to electrical field stimulation. The RSM was included as the phasic tissue for the direct comparison for the role of RhoA prenylation in the phasic versus the tonic smooth muscle of the IAS. The changes in basal IAS tone were expressed as percentage of maximal relaxation by 10 mM EDTA, and increase in IAS tone was expressed as percentage of maximal contraction by 100 M bethanechol at the end of each experiment (Biancani et al., 1985) . The experimental protocol of the study was approved by the institutional Animal Care and Use Committee of Thomas Jefferson University and was in accordance with the recommendations of the American Association for the Accreditation of Laboratory Animal Care.
Drug Responses. Concentration-response curves (CRCs) for U-46619 (1 nM to 10 M) in the IAS smooth muscle strips pretreated for 24 h with GGTI-297 were obtained in a cumulative fashion. The corresponding controls were the responses of the smooth muscle strips incubated for 24 h under the above conditions except for the omission of the pretreatments with GGTI-297.
Immunoprecipitation of Prenylated Proteins and Western Blot Analysis. At the end of incubation tissues were put into liquid N 2 immediately and stored at Ϫ80°C. Later, the respective tissues were cut into small pieces, and homogenization buffer (50 mM HEPES, pH 7.5, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 2 mM NaVO 4 , 25 mM NaF) was added in a volume equal to 5 times the weight. The tissue homogenates were centrifuged (14,000 rpm) for 5 min. Protein concentration in the resultant supernatants was determined by the method of Lowry et al. (1951) using bovine serum albumin as a standard (Pierce Biotechnology, Inc., Rockford, IL).
Prenylated RhoA was immunoprecipitated using Roche Diagnostics immunoprecipitation kit (Protein G) (Fisher, Allentown, PA). Tissue lysate (200 g) in 250-l volume was precleared with 25 l of protein G agarose beads. Precleared lysate was incubated with 1 g of anti-farnesyl rabbit polyclonal antibody (Calbiochem, San Diego, CA) for 1 h (Baron et al., 2000) . Then, 25 l of protein G agarose beads was added and further incubated overnight to immobilize prenylated proteins. Agarose beads were centrifuged for 20 s at 10,000g, and supernatants were transferred to a fresh tube for a fraction containing unprenylated proteins. Agarose beads were washed repeatedly with wash buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate). Later, 50 l of Lamellae sample buffer (LSB; with final concentrations of 62.5 mM Tris, 1% SDS, 15% glycerol, 0.005% bromphenol blue, and 2% ␤-mercaptoethanol) was added to the beads and placed in a boiling water bath for 5 min. Likewise, 20 g of proteins from unprenylated fraction and total tissue lysate were mixed with LSB. Protein samples were separated by 15% SDS-PAGE.
The separated proteins were electrophoretically transferred onto a nitrocellulose membrane (NCM) at 100 V for 1 h at 4°C. To block nonspecific antibody binding, the NCMs were soaked overnight at 4°C in Tris-buffered saline with Tween (TBS-T; composed of 20 mM Tris, pH 7.6, 137 mM NaCl, and 0.1% Tween 20) containing 5% nonfat dry milk. The membrane was then incubated with the RhoA primary antibody raised in rabbit 1:1000 diluted in TBS-T containing 1% milk for 1 h at RT. After washing with TBS-T three times (10 min each wash), the membranes were incubated with the horseradish peroxidase-conjugated bovine anti-rabbit secondary antibody (1: 10,000). The membranes were washed three times with TBS-T, and the corresponding bands were visualized with enhanced chemiluminescence substrate using the SuperSignal West Pico Chemiluminescent Substrate (Pierce Biotechnology Inc.) and Hyperfilm MP (Amersham Biosciences Corp., Piscataway, NJ). Different protein bands on X-ray films were scanned with a scanner (model SNAPSCAN 310; Agfa, Ridgefield Park, NJ), and their relative densities were determined by using Image-Pro Plus 4.0 software (Media Cybernetics, Inc., Silver Spring, MD).
Cytosolic and Particulate Fractionation. The IAS and RSM tissues (both control and incubated with GGTI-297) were homogenized in ice-cold homogenization buffer (10 mM Tris-HCl, pH 7.5, 5 Fig. 1 . Schematics of the molecular changes for RhoA prenylation leading to RhoA/ROCK activation responsible for the basal tone in the IAS. GGTase I catalyzes the covalent attachment of the geranylgeranyl group from GGPP to RhoA (RhoA prenylation). RhoA prenylation plays a critical role in the translocation of RhoA to the membrane followed by the activation of RhoA/ROCK. GGTI-297 blocks RhoA prenylation via inhibiting transfer of geranylgeranyl group to RhoA via inhibition of GGTase I.
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Patel and Rattan at ASPET Journals on July 9, 2017 jpet.aspetjournals.org mM MgCl 2 , 2 mM EDTA, 250 mM sucrose, and 1 mM dithiothreitol). The homogenates were centrifuged at 100,000g for 30 min at 4°C (Beckman L8 -70M Ultracentrifuge; Beckman Coulter, Fullerton, CA). The supernatants were then transferred to a fresh tube and used as the cytosolic fraction. The pellets were resuspended and homogenized in buffer containing 1% Triton X-100. The pellet extract was centrifuged at 800g for 10 min, and the supernatant was collected as the particulate fraction .
Protein extracts (20 g) as prepared above were mixed with LSB and separated by 15% SDS-PAGE. The separated proteins were electrophoretically transferred onto an NCM, RhoA Western blots were performed as described before, and bands were captured on X-ray film. NCMs were then stripped of secondary and primary antibodies by incubating with Restore Western blot stripping buffer (Pierce Biotechnology Inc.) for 15 min at RT and then reprobed for ␣-actin as described earlier .
ROCK Activity Assay. At the end of 24-h incubations with GGTI-297, the tissues were put into liquid N 2 immediately and stored at Ϫ80°C. Later, the respective tissues were cut into small pieces and homogenized in homogenization buffer (in a volume equal to 5 times the weight). The composition of the homogenization buffer was: 50 mM Tris-HCl, pH 7.5, 5 mM EDTA, 10 mM EGTA, 1 mM phenylmethylsulfonyl fluoride, 10 mM benzamide, and 0.3% (w/v) 2-mercaptoethanol. The homogenates were centrifuged (14,000 rpm) for 5 min, and supernatants were collected. Proteins (25 g) in 10 l of lysate were used for kinase assay.
The tissue lysates were mixed with 30 M Long S6 kinase substrate peptide (Upstate, Lake Placid, NY). Kinase assays were initiated by the addition of 10 Ci of [␥-32 P]ATP (3000 Ci/mmol) (Amersham Biosciences Corp.) and 100 M ATP, followed by incubation for 10 min at 30°C. [
32 P]substrate peptide was absorbed onto P81 Whatman phosphocellulose discs (Fisher), and free radioactivity was removed by repeated washings with 75 mM phosphoric acid. The amount of radioactivity on the discs was measured by liquid scintillation. The results were expressed as percentage of the basal activity in the control IAS tissues (Murthy et al., 2003a,b) .
Measurement of Smooth Muscle Cell Lengths. Smooth muscle cells (SMCs) were isolated from the IAS smooth muscle by sequential enzymatic digestion, filtration, and centrifugation as described previously . The cells were cultured in 10-cm plates in DMEM containing 10% fetal bovine serum, 5% penicillin-streptomycin, 50 g/ml gentamicin, and 2 g/ml amphotericin B at 37°C with 5% CO 2 until they attained confluence. Cells were further incubated with GGTI-297 (0.01, 0.1, and 1 M) for 24 h. Control cells were incubated with the vehicle solution only. Individual cell length (in the control state or with a test agent) was measured by computerized image microscopy as described before .
Confocal Microscopy. The SMCs were cultured in DMEM with 10% fetal bovine serum, 5% penicillin-streptomycin, 50 g/ml gentamicin, and 2 g/ml amphotericin B on Lab-Tek II chamber slides (Nulge Nunc International, Naperville, IL) at 37°C and 5% CO 2 in an incubator with humidity. At confluence, culture medium was removed, and the cells were fixed in 4% paraformaldehyde solution in DPBS at RT for 15 min. SMCs were washed three times with DPBS and incubated overnight at RT in a humid environment with 1:100 dilution of RhoA primary antibody (raised in rabbit) (Santa Cruz Biotechnology Inc., Santa Cruz, CA) in DPBS containing 0.2% Triton X-100 and 0.5% bovine serum albumin. SMCs were washed three times with DPBS and incubated with Texas red-conjugated antirabbit secondary antibody (1:200) (Santa Cruz) and fluorescein isothiocyanate-conjugated ␣-actin monoclonal antibody (1:800) (Sigma Chemical Co., St. Louis, MO).) in DPBS with 0.3% Triton X-100 and 2% donkey serum for 1 h. SMCs were then washed three times with DPBS, and chambers were removed from slides.
The slides were then air-dried and coverslipped using Vectashield mounting medium (Vector Labs, Burlingame, CA). Florescence was analyzed with a Bio-Rad MRC 600 laser scanning confocal microscope (Zeiss Anxiovert 100, Overkochen, Germany). Texas Red was excited at 543 nm with a helium/neon laser, and fluorescein isothiocyanate was excited at 488 nm with an argon laser. The fluorophores were detected separately, and overlay images were generated automatically by the imaging software.
Data Analysis. Data are presented as means Ϯ S.E. for the number of animals indicated. Western blot data were expressed as a ratio of relative densities in particulate over cytosolic fractions. Oneway analysis of variance followed by Bonferroni post hoc test was used (p Ͻ 0.05) to calculate statistical significance for comparing more than two groups. CRCs were analyzed using two-way analysis of variance.
Drugs and Chemicals. GGTI-297 was purchased from Calbiochem. U-46619 was purchased from Bachem Bioscience Inc. (King of Prussia, PA). RhoA antibody was purchased from Santa Cruz Biotechnology Inc. ␣-Actin antibody and GGPP were obtained from Sigma Chemical Co. L-15 and DMEM were from Fisher.
Results

Effect of GGTI-297 on the Basal Tone of the IAS.
Twenty-four-hour pretreatment of the tissues with the prenylation inhibitor GGTI-297 caused a concentration-dependent decrease in the basal tone of the IAS. The prenylation inhibitor works by the inhibition of GGTase I and thus blocks the geranylgeranylation of RhoA. GGTI-297 (1 M) caused 71 Ϯ 4.6% inhibition in the basal IAS tone ‫,ء(‬ p Ͻ 0.5; n ϭ 4; Fig. 2A ). Ten minutes of pretreatment of the tissues with the inhibitor, however, produced no change in the basal tone. The GGTase substrate GGPP (10 M) caused significant reversal of the IAS tone inhibited by GGTI-297 ‫,ء(‬ p Ͻ 0.05; n ϭ 3; Fig.   Fig. 2 . A, smooth muscles pretreated with GGTI-297 for 24 h (but not 10 min) reveal a concentration-dependent and significant fall in the basal IAS tone (normalized as 100% in control group) ‫,ء(‬ p Ͻ 0.05; n ϭ 4). The control smooth muscle tissues underwent similar incubation as the pretreated group except that the inhibitor was omitted from the incubation medium. B, fall in the IAS tone caused by GGTI-297 is significantly reversed by GGPP ‫,ء(‬ p Ͻ 0.05; n ϭ 4).
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Effect of GGTI-297 on the U-46619-Induced Contractions of the IAS. Thromboxane A2 analog U-46619 (known to activate RhoA/ROCK; Pang et al., 2005) caused a concentration-dependent increase in the IAS tone (EC max ϭ 59.9 Ϯ 5.1%, EC 50 ϭ 25 nM; n ϭ 6). GGTI-297 (1 M) significantly reduced the effect of U-46619 on IAS (EC max ϭ 29 Ϯ 7.2%; EC 50 ϭ 2.1 M; n ϭ 4; Fig. 3A) . The inhibitory effect of GGTI-297 on U-46619 was significantly reversed by GGPP (10 M) (n ϭ 6; Fig. 3B ). Data suggest that not only the basal tone but also the increase in the IAS tone by the agonist are mediated via RhoA prenylation.
Effect of GGTI-297 on Actual RhoA Prenylation. To authenticate the inhibitory action of GGTI-297 on RhoA prenylation, we immunoprecipitated prenylated and unprenylated proteins using anti-farnesyl rabbit antibody (Baron et al., 2000) . This was followed by the Western blot analysis using RhoA antibody. Anti-farnesyl antibody has been reported to recognize proteins that have been isoprenylated by farnesyltransferase or geranyltransferase. RhoA is geranylgeranylated, rather than farnesylated, by GGTase I (Solski et al., 2002) .
Pretreatment of the IAS tissues for 24 h with selective GGTase I inhibitor GGTI-297 reduced the levels of prenylated RhoA. In contrast, the levels of unprenylated RhoA increased following pretreatment with GGTI-297 ( Fig. 4A ; n ϭ 3). Data suggest the specificity of GGTI-297 (especially in the concentration that caused fall in the IAS tone) in inhibiting RhoA prenylation.
Effect of GGTI-297 on RhoA Localization in the IAS versus RSM. Intracellular location of RhoA was determined by Western blot analyses of the cytosolic and membrane proteins in the IAS versus RSM, before and after pretreatment with GGTI-297. Data revealed higher levels of RhoA in the membrane fraction of the IAS than in the cytosolic fraction in the basal state. GGTI-297 blocked the translocation of RhoA in the IAS, leading to a significant decrease in RhoA in the membrane fraction and an increase in the cytosolic fraction ‫,ء(‬ p Ͻ 0.05; n ϭ 3; Fig. 5, A and B) .
In contrast to IAS, higher levels of RhoA were present in jpet.aspetjournals.org the cytosolic than the particulate fraction in the RSM. GGTI-297 produced no significant change in the levels of RhoA in any of the RSM fractions (p Ͼ 0.05; n ϭ 3, Fig. 6, A and B) . These data suggest that translocation of RhoA in the basal state toward the membrane of the IAS smooth muscle (responsible for the basal tone in the IAS) is critically dependent on RhoA prenylation. Effect of GGTI-297 on ROCK Activity. The effects of RhoA prenylation inhibition by GGTI-297 on ROCK (the immediate target of RhoA) in the IAS were determined by directly monitoring ROCK activity. GGTI-297 in the concentrations of 0.1 and 1 M significantly reduced ROCK activity by 34.8 Ϯ 6.3 and 69.3 Ϯ 2.7%, respectively ‫,ء(‬ p Ͻ 0.05; Fig. 7) .
Effect of GGTI-297 on the SMCs of the IAS versus the RSM. A direct effect of prenylation inhibitor GGTI-297 on the SMCs was confirmed by the concentration-dependent relaxation of the cells isolated from the IAS (Fig. 8) . In this regard, GGTI-297 (1 M) caused maximal relaxation (25.7 Ϯ 3.4%) of the IAS SMCs, whereas it had no significant effect on the RSM SMC.
Molecular Location of RhoA in the IAS SMCs. Confocal microscopy confirmed the cellular location of RhoA. The data revealed significantly higher levels of RhoA toward the periphery of the IAS SMCs as compared with those of the RSM (Fig. 9) . In addition, the prenylation inhibitor caused the redistribution of RhoA to the cytosol in the case of IAS SMC and not in the RSM. These data suggest that in the basal state, RhoA remains in an active state to maintain basal tone in the IAS and that the relaxation of the SMC following GGTI-297 occurs because of the blockade of RhoA translocation via the inhibition of RhoA prenylation.
Discussion
Present studies show for the first time that inhibition of RhoA prenylation inactivates RhoA/ROCK, leading to the decrease in the basal tone in the IAS. Inhibition of RhoA   Fig. 5 . RhoA levels in the particulate versus cytosolic fractions of the IAS smooth muscles before (0) and after GGTI-297 (A). Data are also shown with the RSM in the basal state. B, quantitative information on particulate/cytosolic ratios (adjusted to 100% in the control IAS group). Note concentration-dependent decrease ‫,ء(‬ p Ͻ 0.05; n ϭ 3) in the levels of RhoA in the particulate fractions of the IAS following pretreatment with GGTI-297. Fig. 6 . A, effect of GGTI-297 on the levels of RhoA in the particulate versus cytosolic fractions in the RSM. B, quantitative data to show the ratios of densities in particulate/cytosolic fractions of the RSM. Note in the RSM in contrast to the IAS, GGTI-297 causes no significant change in the levels of RhoA ‫,ء(‬ p Ͻ 0.05; n ϭ 3). Data in the RSM are normalized considering ratios in the control IAS as 100%. Fig. 7 . The RhoA prenylation inhibitor GGTI-297 reduces ROCK activity (an immediate downstream target of RhoA) in the IAS. ROCK activity in the control group is adjusted to 100%. GGTI-297 (0.1 and 1 M) causes a significant decrease in the ROCK activity in the IAS ‫,ء(‬ p Ͻ 0.05; n ϭ 3). Decreases in the ROCK activity are comparable with the basal tone (see Fig. 1A ).
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RhoA/ROCK are known to be present in the cytosol of the SMCs, and during sustained phase of the smooth muscle contraction they translocate to the periphery of the cells for the activation of ROCK (Somlyo and Somlyo, 2003) . Once activated, ROCK inhibits the myosin-binding subunit of myosin light-chain phosphatase, promoting an increase in the levels of phosphorylated-MLC 20 (Kimura et al., 1996; Uehata et al., 1997; Cao et al., 2002; Harnett et al., 2005) . We speculate that the RhoA/ROCK-mediated increase in phosphorylated-MLC 20 is primarily responsible for the maintenance of the basal tone in the IAS (Rattan et al., 2006) . This concept is substantiated by the agonist-induced sustained contraction of different smooth muscles (Ito et al., 2004) .
Isoprenoids such as farnesylpyrophosphate and GGPPs are produced during the cholesterol biosynthesis pathway (Rikitake and Liao, 2005) . These pyrophosphates play a significant role in the post-translational modification of Ras and Rho GTPase, respectively. Prenyltransferase GGTase I attaches the geranylgeranyl group from GGPP to the carboxylterminal cysteine of RhoA (RhoA prenylation). In agreement with this concept, as illustrated in Fig. 1 , GGTI-297 inhibits RhoA geranylgeranylation by inhibiting prenyltransferase GGTase I (Sun et al., 1998; Allai et al., 2000) . The GGTase I inhibitor GGTI-298 has been reported to attenuate agonistinduced contraction of vascular smooth muscles (Shiga et al., 2005) . However, none of the earlier studies used truly tonic smooth muscles that remain contracted spontaneously.
Long incubation (24 h) with GGTI-297 for the inhibition of RhoA prenylation in the IAS is in agreement with the slow turnover of isoprenylation (Shiga et al., 2005) . Following such regimen of pretreatment, GGTI-297 reduces IAS tone and its increase by U-46619. The inhibitory effects of GGTI-297 on IAS are reversible by the GGTase I substrate GGPP. We speculate the role of RhoA prenylation in the IAS tone in the basal state as well as its increase following U-46619. A decrease in IAS tone by the GGTase I inhibitor, GGTI-297, correlates directly with the decrease in the levels of prenylated RhoA.
Different G proteins and GTPases like the Ras, Rap, and Rab family of proteins may be isoprenylated via either farnesylation or geranylgeranylation (Van Aelst and D'SouzaSchorey, 1997) . Present studies focused primarily on the role of isoprenylation of RhoA critically involved in the sustained contraction of different smooth muscles (Somlyo and Somlyo, 2003) . Dependence of basal tone in the IAS smooth muscle on RhoA signal transduction pathway (Rattan et al., 2006) further supports this notion. Additionally, in contrast to RhoA, prenylation of some of the above-mentioned signal transduction proteins is dependent on farnesylation, which is not prone to inhibition by GGTI-297 (Van Aelst and D'SouzaSchorey, 1997; Hall, 1998; Solski et al., 2002) . Present data provide additional support by the significant correlation between the basal tone in the IAS as well as agonist-induced increase and the levels of RhoA prenylation before and after RhoA prenylation inhibitor. In addition, the appropriate substrate GGPP reverses these decreases in the IAS tone caused by the RhoA prenylation inhibitor.
In accordance with the above concept, we observed a significant shift in the levels of RhoA from the membrane to the cytosol in the presence of the GGTase I inhibitor. These data suggest dependence of basal tone on RhoA translocation, which in turn is dependent on RhoA prenylation. It is well known that activation and translocation of RhoA are important processes for the agonist induced Ca 2ϩ sensitization and force generation Somlyo and Somlyo, 2003) . The prenylation status is critical for the translocation of RhoA to the membrane (Adamson et al., 1992) . Interestingly, Gong et al. (1996) reported that prenylated GTP⅐RhoA val14 Ca 2ϩ sensitizes smooth muscle mildly permeabilized with ␤-escin but not with Triton X-100. These data suggest the importance of intact membrane for RhoA translocation. Also, the authors determined that unprenylated GTP⅐RhoA val14 fails to produce the above changes in force that are dependent on Ca 2ϩ sensitization. The IAS serves as the prototype of the tonic smooth muscle since it develops spontaneous tone in the absence of any stimulus, whereas RSM is primarily phasic smooth muscle (Rattan, 2005) . The present studies show high levels of RhoA at membrane and low levels at the cytosol in the IAS, and vice versa in the RSM. These data suggest higher levels of RhoA prenylation and active RhoA are required in the IAS for maintaining higher activity of its downstream target ROCK. In the presence of the prenylation inhibitor, unprenylated RhoA fails to translocate to the membrane, causing a decrease in the basal tone in the IAS. Conversely, in the RSM, GGTI-297 causes no significant change in the location of RhoA. Consistent with this concept, earlier studies have shown the predominance of GDP dissociation inhibitorbound RhoA in the phasic tissues (Somlyo and Somlyo, 2000) .
The immediate and most important downstream target for RhoA (especially the prenylated form) in the smooth muscle is ROCK. Present data provide further evidence that the inhibitory effects of RhoA prenylation inhibitor in the IAS tone are mediated via ROCK inhibition. Active ROCK is important for the maintenance of IAS tone because the ROCK inhibitor Y 27632 almost completely abolishes IAS tone concomitant with the corresponding changes in ROCK activity (Rattan et al., 2006) . In agreement with this concept, present studies show significant correlation for the reduction in ROCK activity and fall in IAS tone in the presence of the prenylation inhibitor.
Although NO is the major inhibitory neurotransmitter for the IAS relaxation Rattan, 2005; Terauchi et al., 2005) , recent studies have shown that the IAS relaxation by ROCK inhibition is independent of NO production in the smooth muscle (Rattan et al., 2006) . The effect of RhoA prenylation inhibitor on the IAS SMC in the present study further demonstrates direct relaxant effect of RhoA/ROCK inactivation on the SMC.
We conclude that RhoA prenylation is essential for membrane localization and downstream signal transduction of RhoA. The studies have important implications in the pathophysiology and on the new concepts in the therapeutic approaches in the rectoanal motility disorders characterized by the hyper-or hypomotility of the sphincteric smooth muscle.
